Cambridge Investment Research Advisors
TAK icon

Cambridge Investment Research Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,418
Closed -$167K – 3952
2025
Q3 		$167K Buy
+11,418
New +$170K ﹤0.01% 3528
2024
Q2 		– Sell
-10,930
Closed -$152K – 3429
2024
Q1 		$152K Buy
10,930
+353
+3% +$5.13K ﹤0.01% 3089
2023
Q4 		$151K Sell
10,577
-5,856
-36% -$83.1K ﹤0.01% 2967
2023
Q3 		$254K Buy
16,433
+883
+6% +$13.7K ﹤0.01% 2629
2023
Q2 		$244K Sell
15,550
-335
-2% -$5.49K ﹤0.01% 2710
2023
Q1 		$262K Buy
15,885
+233
+1% +$3.71K ﹤0.01% 2601
2022
Q4 		$244K Buy
15,652
+637
+4% +$8.9K ﹤0.01% 2595
2022
Q3 		$195K Sell
15,015
-570
-4% -$7.93K ﹤0.01% 2706
2022
Q2 		$219K Buy
15,585
+1,609
+12% +$23K ﹤0.01% 2656
2022
Q1 		$200K Sell
13,976
-3,397
-20% -$49.9K ﹤0.01% 2877
2021
Q4 		$237K Sell
17,373
-1,892
-10% -$26.5K ﹤0.01% 2734
2021
Q3 		$316K Sell
19,265
-1,799
-9% -$30.2K ﹤0.01% 2418
2021
Q2 		$355K Buy
21,064
+500
+2% +$8.51K ﹤0.01% 2346
2021
Q1 		$375K Buy
20,564
+8,317
+68% +$150K ﹤0.01% 2124
2020
Q4 		$223K Sell
12,247
-731
-6% -$12.8K ﹤0.01% 2392
2020
Q3 		$232K Buy
12,978
+1,609
+14% +$29.3K ﹤0.01% 2137
2020
Q2 		$204K Buy
+11,369
New +$204K ﹤0.01% 2161
2019
Q2 		– Sell
-10,352
Closed -$211K – 2343
2019
Q1 		$211K Buy
+10,352
New +$208K ﹤0.01% 2036

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cambridge Investment Research Advisors's TAK Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 11,418 shares — an estimated $167K sold.

Cambridge Investment Research Advisors first reported a position in TAK in Q1 2019 and held it in 18 quarters. The position peaked at $375K in Q1 2021. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,418 Takeda Pharmaceutical shares in Q4 2025, an estimated $167K.
  • Cambridge Investment Research Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 18 quarters.
  • Cambridge Investment Research Advisors's Takeda Pharmaceutical position peaked at $375K in Q1 2021.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.